Pirtobrutinib (Jaypirca)


Indications

Mantle Cell Lymphoma (see Lymphoma)

Clinical Efficacy


Pharmacology

Bruton’s Tyrosine Kinase (BTK) Inhibitor

Metabolism


Administration

Oral (PO)

Dose Adjustment

Use in Pregnancy (see Pregnancy)

Use During Breast Feeding


Adverse Effects

Pulmonary Adverse Effects

Cough (see Cough)

Pneumonia (see xxxx)


References